Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjoncology logo
VJHemOnc
Logo
  • Home (current)
  • Diseases
    CLL
    Multiple Myeloma
    Myeloproliferative Neoplasms
    ALL
    AML
    Lymphoma
    View all Diseases
  • Topics
    Transplantation
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    View all Topics
  • Conferences
    ASH
    2019
    MPN Advances Day
    2019
    iwCAR-T
    2019
    COSTEM
    2019
    ESMO
    2019
    iwCLL
    2019
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

Isatuximab

12:03
How will novel agents affect the amyloidosis population?
Morie Gertz et al.
13:14
Amyloidosis: diagnosis and stem cell transplantation
Morie Gertz et al.
1:11
Attacking plasma cell dyscrasia in AL amyloidosis
Vaishali Sanchorawala
10:42
Highlights from IMW 2019 Part I
Francesca Gay et al.
1:55
Katja Weisel: GMMG-CONCEPT
Katja Weisel
5:22
Updates on German clinical trials in multiple myeloma
Marc Raab
7:37
Prevention and management of adverse events in relapsed myeloma
Michel Delforge
3:30
Isatuximab: an important new option in R/R MM
Paul Richardson
1:24
Multiple myeloma treatment strategies: what does the future hold?
Enrique Ocio
2:24
Drug trial updates in multiple myeloma and SMM
Enrique Ocio
5:22
ICARIA study: Isatuximab and pom/dex for multiple myeloma
Paul Richardson
3:23
Upcoming updates in multiple myeloma
Thierry Facon
6:09
Induction in myeloma: a journey over time
Mohamad Mohty
3:11
Isatuximab plus VRd for newly diagnosed transplant-ineligible myeloma
Enrique Ocio
04:22
Mohamad Mohty’s myeloma highlights from ASH 2018
Mohamad Mohty
1:46
CD38 antibodies under investigation for myeloma: isatuximab, MOR202 & TAK-079
Niels van de Donk
  • 1
  • 2
  • Next
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign up
Disease Channels
  • CLL
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • ALL
  • AML
  • Lymphoma
  • View all
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up
mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJHemOnc logo
The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy